A new fund just launched (NFO) — should you jump in?
A new mutual fund just launched. Should you invest in it on day one?
It's called an NFO — a New Fund Offer, the initial subscription window for a brand new mutual fund scheme.
₹10 doesn't mean cheap
NFOs are typically launched at ₹10 per unit, and that number trips people up. ₹10 doesn't mean "cheap." A unit price alone tells you nothing about whether a fund is cheap or expensive — what actually matters is the underlying portfolio, its costs, and its future returns, not the number printed on the unit.
The bigger problem: no track record
This scheme has no performance history yet. You can't see how it would have handled a market fall, because it hasn't been through one. You can still look at the fund manager's track record on other schemes and the AMC's overall reputation — just not this scheme's own returns, because there aren't any yet.
Remember ₹10 per unit does NOT mean a mutual fund is cheap. A fund's NAV tells you the value per unit — not whether the underlying investments are attractively priced.
A real-world example
Invesco recently opened an NFO for a Pharma and Healthcare Fund — and it's broader than a plain pharma fund, covering hospitals, diagnostics, and healthcare services too. If an existing fund already gives you similar exposure and has a real multi-year track record, that's simply more evidence to evaluate than a brand-new scheme with none.
So, should you invest in an NFO?
New doesn't automatically mean better, and ₹10 doesn't automatically mean cheap. NFOs aren't bad by default — just don't buy one only because the unit price looks low.
Note: I am not a SEBI-registered investment advisor. This article is for educational purposes only and is not investment advice. Please consult a registered financial advisor before making investment decisions.